Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)
This study has been completed.
Sponsor:
Swedish Orphan Biovitrum
Collaborator:
Amgen
Information provided by (Responsible Party):
Swedish Orphan Biovitrum
ClinicalTrials.gov Identifier:
NCT00109031
First received: April 22, 2005
Last updated: July 13, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2010 |
| Primary Completion Date: | February 2006 (Final data collection date for primary outcome measure) |